Scientific work

Prof. Dr. Aydoğan Aydoğdu

144 publications. The source of the information is stated next to each publication.

Back to profile

  1. Uluslararası bilimsel toplantılarda sunulan ve bildiri kitaplarında (proceedings) basılan bildiriler (sözel-poster)

    Source: medicana.com.tr profile page

  2. Ulusal bilimsel toplantılarda sunulan ve bildiri kitaplarında (proceedings) basılan bildiriler

    Source: medicana.com.tr profile page

  3. 1.Tasci I, Cintosun U, Safer U, Naharci MI, Bozoglu E, Aydogdu A, Doruk H. Assessment of geriatric predictors of adherence to Zoledronic acid treatment for osteoporosis: a prospective follow-up study. Acta Clin Belg. 2018;73:237-243.

    Source: medicana.com.tr profile page

  4. 2.Increased Endothelial Dysfunction and Insulin Resistance in Patients with Klinefelter Syndrome. Haymana C, Aydogdu A, Demirci I, Dinc M, Demir O, Torun D, Yesildal F, Meric C, Basaran Y, Sonmez A, Azal O. Endocr Metab Immune Disord Drug Targets. 2018;18(4):401-406.

    Source: medicana.com.tr profile page

  5. 3.Haymana C, Aydoğdu A, Soykut B, Erdem O, Ibrahimov T, Dinc M, Meric C, Basaran Y, Sonmez A, Azal O., Oxidative stress status in congenital hypogonadism: an appraisal. Toxicol Mech Methods. 2017 May 2:1-7. doi: 10.1080/15376516.2017.1320693.

    Source: medicana.com.tr profile page

  6. 4.Haymana C, Sonmez A, Aydogdu A, Tapan S, Basaran Y, Meric C, Baskoy K, Taslipinar A, Yilmaz MI, Azal O., Effect of Testosterone Replacement Therapy on Vitamin D and FGF-23 Levels in Congenital Hypogonadism. Endokrynol Pol. 2017 Feb 23. doi: 10.5603/EP.a2017.0009

    Source: medicana.com.tr profile page

  7. 5.Haymana C, Sonmez A, Aydogdu A, Tapan S, Basaran Y, Meric C, Baskoy K, Dinc M, Yazici M, Taslipinar A, Barcin C, Yilmaz MI, Bolu E, Azal O. Visceral adiposity index and triglyceride/high-density lipoprotein cholesterol ratio in hypogonadism. Arch Endocrinol Metab. 2017 Feb 13:0. doi: 10.1590/2359-3997000000236.

    Source: medicana.com.tr profile page

  8. 6.Sönmez A, Dinç M, Taşlıpınar A, Aydoğdu A, Meriç C, Başaran Y, Haymana C, Demir O, Yılmaz İ, Azal Ö. Add on Exenatide Treatment is Beneficial in Poorly Controlled Obese Type 2 Diabetics under Intensive Insulin Regimens. Exp Clin Endocrinol Diabetes. 2017 Apr;125(4):256-261

    Source: medicana.com.tr profile page

  9. 7.Aydogdu A, Swerdloff RS. Emerging medication for the treatment of male hypogonadism. Expert Opin Emerg Drugs. 2016 Sep;21(3):255-66

    Source: medicana.com.tr profile page

  10. 8.Tasci I, Safer U, Cintosun U, Bozoglu E, Naharci I, Aydogdu A, Meric C, Doruk H. Zoledronic Acid Use and Risk of Cognitive Decline among Elderly Women and Men with Osteoporosis. Endocr Metab Immune Disord Drug Targets. 2016;16(1):32-8.

    Source: medicana.com.tr profile page

  11. 9.Bayram F, Elbuken G, Korkmaz C, Aydogdu A, Karaca Z, Cakır I. The Effects of Gonadotropin Replacement Therapy on Metabolic Parameters and Body Composition in Men with Idiopathic Hypogonadotropic Hypogonadism. Horm Metab Res. 2016 Feb;48(2):112-7.

    Source: medicana.com.tr profile page

  12. 10.Aydogdu A, Haymana C, Soykut B, Erdem O, Basaran Y, Baskoy K, Dinc M, Taslipinar A, Sonmez A, Bolu E, Azal O. Trace Element Levels in Congenital Hypogonadotrophic Hypogonadism. Biol Trace Elem Res. 2016 May;171(1):26-32.

    Source: medicana.com.tr profile page

  13. 11.Sonmez A, Haymana C, Aydogdu A, Tapan S, Basaran Y, Meric C, Baskoy K, Dinc M, Yazici M, Taslipinar A, Barcin C, Yilmaz MI, Bolu E, Azal O. Endothelial dysfunction, insulin resistance and inflammation in congenital hypogonadism, and the effect of testosterone replacement. Endocr J. 2015;62(7):605-13.

    Source: medicana.com.tr profile page

  14. 12.Osteoprotegerin, fibroblast growth factor 23, and vitamin D3 levels in male patients with hypogonadism. Meric C, Sonmez A, Aydogdu A, Tapan S, Haymana C, Basaran Y, Baskoy K, Sertoglu E, Taslipinar A, Bolu E, Azal O. Horm Metab Res. 2014; 46: 955-958.

    Source: medicana.com.tr profile page

  15. 13.Combined choroidal neovascularization and hypopituitarism in a patient with homozygous mutation in methylenetetrahydrofolate reductase gene. Aydogdu A, Haymana C, Baskoy K, Durukan AH, Ozgur G, Azal O. J Res Med Sci. 2014;19: 75-79.

    Source: medicana.com.tr profile page

  16. 14.Comparison of estimated GFR equations based on serum cystatin C alone and in combination with serum creatinine in patients with coronary artery disease. Doğaner YÇ, Aydoğan Ü, Rohrer JE, Aydoğdu A, Çaycı T, Barçın C, Sağlam K. Anadolu Kardiyol Derg. 2014; 16. doi: 10.5152/akd.2014.5535.

    Source: medicana.com.tr profile page

  17. 15.Effects of valsartan treatment on serum ghrelin level and left ventricular mass index in patients with untreated primary hypertension. Meriç C, Aydoğdu A, Taşçı İ, Deniz F, Baysan O, Serdar M, Sağlam K, Azal Ö. Anadolu Kardiyol Derg. 2014; 14: 234-238.

    Source: medicana.com.tr profile page

  18. 16.Relationship of cystatin C with coronary artery disease and its severity. Doganer YC, Aydogan U, Aydogdu A, Aparci M, Akbulut H, Nerkiz P, Turker T, Cayci T, Barcin C, Saglam K. Coron Artery Dis. 2013; 24: 119-126.

    Source: medicana.com.tr profile page

  19. 17.The effect of levothyroxine replacement therapy on lipid profile and oxidative stress parameters in patients with subclinical hypothyroid. Mutlu S, Parlak A, Aydogan U, Aydogdu A, Soykut B, Akay C, Saglam K, Taslipinar A. Arch Pharm Res. 2013 Aug 8.

    Source: medicana.com.tr profile page

  20. 18.Cognitive and functional influences of vildagliptin, a DPP-4 inhibitor, added to ongoing metformin therapy in elderly with type 2 diabetes. Tasci I, Naharci MI, Bozoglu E, Safer U, Aydogdu A, Yilmaz BF, Yilmaz G, Doruk H. Endocr Metab Immune Disord Drug Targets. 2013; 13: 256-263.

    Source: medicana.com.tr profile page

  21. 19.HDL cholesterol subfractions and the effect of testosterone replacement in hypogonadism. Bolu E, Sonmez A, Tapan S, Taslipinar A, Aydogdu A, Meric C, Basaran Y, Uckaya G, Serdar M, Kurt I, Azal O. Horm Metab Res. 2013; 45: 443-448.

    Source: medicana.com.tr profile page

  22. 20.Effects of three different medications on metabolic parameters and testicular volume in patients with hypogonadotropic hypogonadism: 3-year experience. Aydogdu A, Bolu E, Sonmez A, Tasci I, Haymana C, Acar R, Meric C, Taslipinar A, Ozgurtas T, Azal O. Clin Endocrinol (Oxf). 2013; 79: 243-251.

    Source: medicana.com.tr profile page

  23. 21.Brain derived neurotrophic factor (BDNF) in cardiometabolic physiology and diseases. Taşçı İ, Kabul HK, Aydoğdu A. Anadolu Kardiyol Derg. 2012; 12: 684-688.

    Source: medicana.com.tr profile page

  24. 22.Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions. Aydogan U, Aydogdu A, Akbulut H, Sonmez A, Yuksel S, Basaran Y, Uzun O, Bolu E, Saglam K. Endocr J. 2012; 59: 1099-1105.

    Source: medicana.com.tr profile page

  25. 23.Increase in subcutaneous adipose tissue and fat free mass in women with polycystic ovary syndrome is related to impaired insulin sensitivity. Aydogdu A, Tasci I, Kucukerdonmez O, Tapan S, Aydogdu S, Aydogan U, Sonmez A, Yazici M, Azal O. Gynecol Endocrinol. 2013 Feb;29(2):152-5.

    Source: medicana.com.tr profile page

  26. 24.Women with polycystic ovary syndrome have increased plasma chitotriosidase activity: a pathophysiological link between inflammation and impaired insulin sensitivity? Aydogdu A, Tasci I, Tapan S, Sonmez A, Aydogan U, Akbulut H, Uckaya G, Aydogdu S, Basaran Y, Meric C, Taslipinar A, Kurt I, Azal O. Exp Clin Endocrinol Diabetes. 2012; 120: 261-265.

    Source: medicana.com.tr profile page

  27. 25.The relationship of epicardial adipose tissue thickness to clinical and biochemical features in women with polycystic ovary syndrome. Aydogdu A, Uckaya G, Tasci I, Baysan O, Tapan S, Bugan B, Serdar M, Akbulut H, Aydogan U, Sonmez A, Aydogdu S, Kutlu M. Endocr J. 2012; 59: 509-16.

    Source: medicana.com.tr profile page

  28. 26.Abdominal obesity is associated with a lower ankle-brachial index in women with polycystic ovary syndrome. Dogan MI, Tasci I, Bulucu F, Aydogdu A, Acar R, Ceyhan T, Koc B, Demir O, Gezer M, Saglam K. Angiology. 2013; 64: 105-11.

    Source: medicana.com.tr profile page

  29. 27.High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome. Aydogdu A, Tasci I, Tapan S, Basaran Y, Aydogan U, Meric C, Sonmez A, Aydogdu S, Akbulut H, Taslipinar A, Uckaya G, Azal O. Gynecol Endocrinol. 2012; 28: 722-725.

    Source: medicana.com.tr profile page

  30. 28.Metabolic syndrome and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism. Sonmez A, Haymana C, Bolu E, Aydogdu A, Tapan S, Serdar M, Altun B, Barcin C, Taslipinar A, Meric C, Uckaya G, Kutlu M. Eur J Endocrinol. 2011 May;164(5):759-64.

    Source: medicana.com.tr profile page

  31. 29.Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus. Sonmez A, Haymana C, Tapan S, Safer U, Celebi G, Ozturk O, Genc H, Dogru T, Tasci I, Erdem G, Taslipinar A, Aydogdu A, Yilmaz MI, Kurt I, Kutlu M. Endocrine. 2010; 37: 455-459.

    Source: medicana.com.tr profile page

  32. 30.The accuracy of home glucosemeters in hypoglycemia. Sonmez A, Yilmaz Z, Uckaya G, Kilic S, Tapan S, Taslipinar A, Aydogdu A, Yazici M, Yilmaz MI, Serdar M, Erbil MK, Kutlu M. Diabetes Technol Ther. 2010; 12: 619-626.

    Source: medicana.com.tr profile page

  33. 31.HDR syndrome (hypoparathyroidism, sensorineural deafness and renal disease) accompanied by renal tubular acidosis and endocrine abnormalities. Taslipinar A, Kebapcilar L, Kutlu M, Sahin M, Aydogdu A, Uckaya G, Azal O, Bolu E, Ibrahim Aydin H. Intern Med. 2008;47(11):1003-7.

    Source: medicana.com.tr profile page

  34. 32.The relationship between severity of coronary artery disease and plasma level of vascular endothelial growth factor. Kucukardali Y, Aydogdu S, Ozmen N, Yonem A, Solmazgul E, Ozyurt M, Cingozbay Y, Aydogdu A. Cardiovasc Revasc Med. 2008; 9: 66-70.

    Source: medicana.com.tr profile page

  35. 33.Effect of Helicobacter pylori infection and eradication therapy on interleukin-6 levels in patients with Familial Mediterranean Fever. Ozel AM, Demirturk L, Aydogdu A, Gultepe M, Yazgan Y, Imirzalioglu N, Gurbuz AK, Narin Y. Int J Clin Pract. 2008; 62: 754-761.

    Source: medicana.com.tr profile page

  36. 1.U. Aydoğan, H Akbulut, D.E. Gök, Y. C. Doğaner, O. Sarı, M.İ. Yılmaz, Z. Şenses, M. Kuşkucu, A. Aydoğdu, K. Sağlam, The 3rd Eurasia Congress Of İnfectious Diseases konferansı dahilinde "Congress Book and Abstracts" bildiri kitapçığındaki "The prevalance of anti-HCV and HbsAg ın hemodialysis patients. The 3rd Eurasia Congress Of Infectious Diseases", 208 pp., Bakü, Azerbeycan, 01-04 Ekim 2009

    Source: medicana.com.tr profile page

  37. 2.U. Aydoğan, H. Akbulut, D.E. Gök, Y. C. Doğaner, O. Sarı, M.İ. Yılmaz, Z. Şenses, M. Kuşkucu, A. Aydoğdu, K. Sağlam, The 3rd Eurasia Congress Of İnfectious Diseases konferansı dahilinde "Congress Book and Abstracts" bildiri kitapçığındaki "Hemodialysis patients carrying nasal staphylococcus aureus and meticilin resistance.", 207 pp., Bakü, Azerbeycan, Ekim 2009

    Source: medicana.com.tr profile page

  38. 3.A. Sönmez, Z. Yılmaz, G. Üçkaya, S. Tapan, A. Taşlıpınar, A. Aydoğdu, M. Yazıcı, H. Turan, E. Bolu, O. Azal, A. Çorakçı, M. Kutlu., 20th World Diabetes Congress konferansı dahilinde "Abstract Book" bildiri kitapçığındaki "Are glucometers sensitive enough to detect hypoglycemia?", 379 pp., Montreal, Kanada, Ekim 2009

    Source: medicana.com.tr profile page

  39. 4.A. Aydoğdu, H. Akbulut, G. Üçkaya, A. Taşlıpınar, A. Sönmez, U. Aydoğan, M. Kutlu, 12th European Congress Of Endocrinology konferansı dahilinde "Endocrine Abstracts" bildiri kitapçığındaki "Carcaneal spur ıncidence ıs ıncreased ın patients with type 2 diabetes mellitus", p320 pp., Prag, Çek Cumhuriyeti, Nisan, 2010

    Source: medicana.com.tr profile page

  40. 5.A. Aydoğdu, Ö. Küçükerdönmez, G. Üçkaya, A. Taşlıpınar, E. Bolu, A. Sönmez, U. Aydoğan, M. Kutlu, 12th European Congress Of Endocrinology, konferansı dahilinde "Endocrine Abstracts" bildiri kitapçığındaki "Waist circumference does not reflect body fat distribution and insulin resistance ın young male patients with idiopathic hypogonadotropic Hypogonadism", p697 pp., Prag, Çek Cumhuriyeti, Nisan 2010

    Source: medicana.com.tr profile page

  41. 6.A. Sönmez, C. Haymana, E. Bolu, S. Tapan, C. Barçın, A. Aydoğdu, A.Taşlıpınar, M. Kutlu, 12th European Congress Of Endocrinology konferansı dahilinde "Endocrine Abstracts" bildiri kitapçığındaki "Searching for the metabolic syndrome criteria ın young adults with hypogonadism", P148 pp., Prag, Çek Cumhuriyeti, Nisan 2010

    Source: medicana.com.tr profile page

  42. 7.M.Y. Yarpuz, U. Aydoğan, O. Sarı, A. Aydoğdu, G . Üçkaya, K. Sağlam., 2nd Congress Of Association Of General Practice/Family Medicine Of South Easth Europe konferansı dahilinde "Abstracts' Book" bildiri kitapçığındaki "The effect of thyroid replacement therapy to levels of anxiety and depression in subclinical hypothyroid patients.", 198 pp., Antalya, Türkiye, Nisan 2010

    Source: medicana.com.tr profile page

  43. 8.U. Aydoğan H. Akbulut, A. Parlak, O. Sarı, A. Aydoğdu, C. Barçın, K. Sağlam., 19th Wonca World Conference of Family Doctors konferansı dahilinde "Abstracts" bildiri kitapçığındaki "Coronary artery disease, comorbid diseases and pharmaceutical drug usage.", 384 pp., Cancun, Meksika, Mayıs 2010

    Source: medicana.com.tr profile page

  44. 9.U. Aydoğan, H. Akbulut, A. Aydoğdu, Y.C. Doğaner, E. Bolu, K. Sağlam, 2nd Congress Of Association Of General Practice/Family Medicine Of South Easth Europe konferansı dahilinde "Abstracts' Book" bildiri kitapçığındaki "Complications and comorbid diseases in type 2 diabetic patients.", 221 pp., Antalya, Türkiye, Nisan 2010

    Source: medicana.com.tr profile page

  45. 10.A. Aydoğdu, U. Aydoğan, H. Akbulut, O. Sarı, E. Bolu, K. Sağlam., 2nd Congress Of Association Of General Practice/Family Medicine Of South Easth Europe konferansı dahilinde "Abstracts' Book" bildiri kitapçığındaki "Anxiety levels ın patients diagnosed with and being treated for hypogonadism.", 221 pp., Antalya, Türkiye, Nisan 2010

    Source: medicana.com.tr profile page

  46. 11.A. Aydoğdu, S. Aydoğdu, U. Aydoğan, C. Meriç, H. Akbulut, S. Yüksel, O. Sarı, G. Üçkaya, A. Sönmez, A. Taşlıpınar, M. Kutlu., 2nd International Meeting Of Hypertension And Diabetes Primary Care konferansı dahilinde "Abstract Book" bildiri kitapçığındaki "The frequency of prediabetes and diabetes mellitus in young obese male adolescents", 57 pp., İstanbul, Türkiye, Nisan 2011

    Source: medicana.com.tr profile page

  47. 12.H. Akbulut, U. Aydoğan, A. Aydoğdu, P. Nerkiz, C. Barçın, Y.C. Doğaner, T. Türker, K. Sağlam., 2nd International Meeting Of Hypertension And Diabetes Primary Care konferansı dahilinde "Abstract Book" bildiri kitapçığındaki "Comparison of the results of elective angiography with exercise stress testing results", 56 pp., İstanbul, Türkiye, Nisan 2011

    Source: medicana.com.tr profile page

  48. 13.Y.C. Doğaner, U. Aydoğan, A. Aydoğdu, P. Nerkiz, O. Sarı, H. Akbulut, C. Barçın, K. Sağlam, K. 2nd International Meeting Of Hypertension And Diabetes Primary Care konferansı dahilinde "Abstract Book" bildiri kitapçığındaki "Relationship between diabetes mellitus and coronary artery disease", 53 pp., İstanbul, Türkiye, Nisan 2011

    Source: medicana.com.tr profile page

  49. 14.A. Sonmez, C. Haymana, E. Bolu, A. Aydogdu, S. Tapan, M. Serdar, B. Altun, C. Barcin, A. Taslipinar, C. Meric, G. Uckaya, M. Kutlu., 13th European Congress of Endocrinology konferansı dahilinde "Endocrine Abstracts" bildiri kitapçığındaki "Metabolic Syndrome and the effect of testosterone treatment in young men with hypogonadotropic hypogonadism", P562 pp., Rotterdam, Hollanda, Nisan 2011

    Source: medicana.com.tr profile page

  50. 15.A. Aydogdu, G. Uckaya, I. Tascı, O. Baysan, S. Tapan, B. Bugan, M. Serdar, S. Aydogdu, H. Akbulut, U. Aydogan, A. Sonmez, O. Azal, 15th Internatıonal, 14th European Congrees of Endocrınology konferansı dahilinde "Endocrine Abstracts" bildiri kitapçığındaki "Epicardial adipose tissue thickness in patients with polycystic ovary syndrome", p963 pp., Floransa, İtalya, Mayıs 2012

    Source: medicana.com.tr profile page